Clinical Trials in Houston

Showing 1661-1680 of 15,366 trials

Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma

NCT06105554

Phase 1 is to find the recommended dose of belumosudil mesylate that can be given to patients with relapsed/refractory MM. Phase 2 is to learn if the dose of belumosudil mesylate found in Phase 1 can help to control the disease.

Multiple Myeloma

M.D. Anderson Cancer Center36 participantsStarted Jan 2024

Houston, Texas, United States

RECRUITINGPhase 2/3< 1 mile

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

NCT06581406

The purpose of this study is to measure the clinical benefits of the combination of RP2 and nivolumab as compared with the combination of nivolumab and ipilimumab in patients with metastatic uveal melanoma who have not been treated with immune checkpoint inhibitor therapy.

Metastatic Uveal Melanoma

Replimune Inc.280 participantsStarted Dec 2024

Scottsdale, Arizona, United States • La Jolla, California, United States • Los Angeles, California, United States +28 more locations

Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Find Trials by Condition in Houston

J-Valve Transfemoral Pivotal Study

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

Product Surveillance Registry

A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats

Longitudinal Early-onset Alzheimer's Disease Study Protocol

Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease

ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

Study of Safety and Performance of a Novel Ocular Lubricant in Subjects With Dry Eye Disease

Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

SPARK-ALL: Calaspargase Pegol in Adults With ALL

Effectiveness Trial of Mobile ESI for Toddlers With Autism Identified by Early Screening in Primary Care

A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma